Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precise and Objective Identification of Bertolotti Syndrome Using Novel Kinematic Biomarkers

NCT06225583 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT06225583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06225583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precise and Objective Identification of Bertolotti Syndrome Using Novel Kinematic Biomarkers
Lead sponsor
The Cleveland Clinic
Phase
Observational
Overall status
Active, not recruiting
Start date
January 17, 2024
Completion date
December 31, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bertolotti's syndrome, lower back pain